NewAmsterdam Pharma Co NV (NAMS) PT Lowered to $42 at RBC Capital

October 5, 2026 7:02 AM

(Updated - October 5, 2026 8:54 AM EDT)

RBC Capital analyst Leonid Timashev lowered the price target on NewAmsterdam ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found